Plain-English translation of NCT01600378 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research study that gathers information from patients diagnosed with diffuse parenchymal lung diseases — conditions where damage is spread across both lungs. By collecting detailed medical records, test results, imaging scans, and tissue samples from patients like you, researchers are building a comprehensive database to understand these diseases better and improve how doctors diagnose and treat them.
Diffuse lung diseases are complex and can have many different causes, but there isn't enough data about how common they are, how they progress, or which treatments work best. This study exists to fill that gap by creating a detailed picture of these diseases in the Singapore population.
You likely qualify if…
You likely don't qualify if…
If you enroll, your doctors will collect information about your lung disease from your medical visits, breathing tests, imaging scans (like X-rays or CT scans), and possibly tissue samples if you've had a biopsy. This information goes into a research database that helps doctors understand disease patterns and outcomes. You'll likely be followed over time as part of the registry — there is no experimental treatment being given; instead, researchers are simply documenting your existing care and how your condition evolves.
AI-generated summary from trial data · Jun 8, 2026 · Not medical advice
Singapore
Sponsor
Singapore General Hospital
Enrollment target
~500 participants
Started
May 2012
Primary completion
December 2030
Age range
21 Years – 90 Years
Last updated on clinicaltrials.gov in April 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Su Ying Low, BMBCh
Singapore General Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.